You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 11, November 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Secondary Biliary Cirrhosis

A Limiting Factor in the Treatment of Hepatolithiasis

Kuo-Shyang Jeng, MD; Shou-Chuan Shih, MD; Hsein-Jar Chiang, MD; Bee-Fong Chen, MD

Arch Surg. 1989;124(11):1301-1305.


Abstract

• To investigate whether the coexistence of secondary biliary cirrhosis plays a limiting role in the treatment of hepatolithiasis, we retrospectively compared the clinical course and results of stone treatment in 30 patients with secondary biliary cirrhosis (8 in Child's class A and 22 in Child's class B) (group 1) and 240 patients with noncirrhotic biliary calculi (group 2). The hospital mortality, morbidity of treatment, mortality of treatment, and the percentage of treatment failure in group 1 were 20%, 40%, 6.7%, and 16.7%, respectively. Those in group 2 were 8%, 10%, 3.8%, and 10%, respectively. The modes of treatment for stone removal included surgery with postoperative cholangioscopy and percutaneous transhepatic cholangioscopy. There was a statistically significant difference between these two groups in the hospital mortality and the morbidity of treatment. We conclude that hepatolithiasis and biliary stricture should be treated early, before the development of secondary biliary cirrhosis. However, even after cirrhosis occurs, aggressive treatment does not increase the mortality of treatment or the treatment failure rate.

(Arch Surg. 1989;124:1301-1305)



Author Affiliations

From the Departments of Surgery (Dr Jeng), Gastroenterology (Dr Shih), Radiology (Dr Chiang), and Pathology (Dr Chen), Mackay Memorial Hospital, Taipei City, Taiwan.


Footnotes

Accepted for publication April 3, 1989.

Reprint requests to Department of Surgery, Mackay Memorial Hospital, No. 92, Section 2, Chung-Shan North Road, Taipei City, Taiwan 10449, Republic of China (Dr Jeng).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Are Expandable Metallic Stents Better Than Conventional Methods for Treating Difficult Intrahepatic Biliary Strictures With Recurrent Hepatolithiasis?
Jeng et al.
Arch Surg 1999;134:267-273.
ABSTRACT | FULL TEXT  

Ductal dilatation and stenting for residual hepatolithiasis: a promising treatment strategy
Sheen-Chen et al.
Gut 1998;42:708-710.
ABSTRACT | FULL TEXT  

Reappraisal of the Systematic Management of Complicated Hepatolithiasis With Bilateral Intrahepatic Biliary Strictures
Jeng et al.
Arch Surg 1996;131:141-147.
ABSTRACT  

Coexisting Sharp Ductal Angulation With Intrahepatic Biliary Strictures in Right Hepatolithiasis
Jeng et al.
Arch Surg 1994;129:1097-1102.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.